In hepatocellular carcinoma (HCC), ACSL3 and ACSL4 have been extensively studied, with several studies indicating differential expression of these enzymes in normal liver tissue, metastatic liver lesions, and HCC tissues. This evidence concerns the gene ACSL3 and hepatocellular carcinoma.